Clinical study demonstrates improved diagnostic performance of MCE in upper gastrointestinal tract, suggesting better patient tolerance.
Esophagogastroduodenoscopy (EGD) is the standard diagnostic modality for upper gastrointestinal (UGI) diseases, but its invasive nature and the risk of sedation-related adverse events limit its applicability in certain patients. Magnetically controlled capsule endoscopy (MCE) is a promising noninvasive alternative, enabling precise active locomotion and complete visualization of the gastric mucosa through external magnetic control. MCE systems have evolved into hand-held and robotic systems, with clinical studies showing diagnostic performance comparable to EGD, along with generally better patient tolerance. Recent studies have shown that a single MCE examination can simultaneously evaluate the UGI tract and small bowel. Advances such as three-dimensional imaging and artificial intelligence have improved diagnostic accuracy and workflow efficiency. Although cost-effectiveness remains a challenge in Korea's healthcare environment, MCE provides a meaningful alternative for patients who are unsuitable for sedated EGD or who prefer a noninvasive modality. With the ongoing technological advances, MCE is expected to evolve into an autonomous, "One-stop pan-enteric endoscopy" platform in the near future.
No takes yet. Share an insight, caveat, or question.
Oh et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: